| Oct 1 |
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
|
| Sep 30 |
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
|
| Sep 25 |
Does Corcept Therapeutics (CORT) Have a Long Runway for Growth?
|
| Sep 19 |
Corcept (CORT) Moves 6.5% Higher: Will This Strength Last?
|
| Sep 18 |
Forecasting The Future: 6 Analyst Projections For Corcept Therapeutics
|
| Sep 15 |
Corcept Therapeutics - Three Dynamic Catalysts To Reaccelerate Growth
|
| Sep 10 |
Do Options Traders Know Something About Corcept (CORT) Stock We Don't?
|
| Sep 9 |
US Growth Companies With High Insider Ownership
|
| Sep 6 |
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
|
| Sep 5 |
Here's Why Corcept Therapeutics (NASDAQ:CORT) Has Caught The Eye Of Investors
|
